Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Immunome, Inc. (IMNM) had Return on Investments of -13.93% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-73.13M |
|
-- |
|
-- |
|
$78.14M |
|
$-78.14M |
|
$5.01M |
|
$-73.13M |
|
$-73.13M |
|
$-73.13M |
|
$-73.13M |
|
$-73.13M |
|
$-73.13M |
|
$-78.14M |
|
$-77.42M |
|
113.27M |
|
113.27M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$538.45M |
|
$17.36M |
|
$26.93M |
|
$565.38M |
|
$35.71M |
|
-- |
|
$4.59M |
|
$40.30M |
|
$525.08M |
|
$525.08M |
|
$525.08M |
|
113.40M |
|
| Cash Flow Statement Financials | |
$-120.33M |
|
$-316.37M |
|
$0.92M |
|
$653.69M |
|
$217.92M |
|
$-435.78M |
|
$16.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-125.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.93% |
|
-13.93% |
|
-12.93% |
|
|
Return on Investments |
-13.93% |
$4.63 |
|
$-1.11 |
|
$-1.06 |
|